By Sriparna Roy and Juveria Tabassum Feb 18 (Reuters) - Global food and beverage companies from PepsiCo to Coca-Cola are ...

New data reveals rising abdominal obesity in India, with visceral fat increasing risks of type 2 diabetes, heart disease, and ...

Electronic health records and kiosk data provide alternative measurements of obesity, capturing prevalence across geographic US regions.

The European Commission (EC) has approved a higher dose of Novo Nordisk’s Wegovy (semaglutide), marking a win for the ...

Researchers say negative childhood experiences such as physical abuse, sexual abuse, neglect, bullying and parents divorcing may increase the risk of obesity in children and adults.

Cash-strapped US consumers are seeking cheaper options as the cost of living rises and weight-loss drugs become more available.

At 36 weeks in the TOGETHER-PsO study, concomitant Taltz and Zepbound met primary endpoint of superiority vs. Taltz monotherapy in achieving complete skin clearance ...

The people most likely to use weight loss jabs, according to new research - Almost 80 per cent of private prescriptions for ...

Inhaled corticosteroids are strongly recommended, in addition to streamlined management with combination and step-up therapy.

A pending court complaint alleges bias after the regulator voted to block radio advertisements about the dangers of sugar.

Novo Nordisk NVO announced that the European Commission (EC) has approved a new 7.2 mg once-weekly maintenance dose of Wegovy (semaglutide injection) for adults with obesity. This provides physicians ...